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Background
Visible chromosome abnormalities have been commonly
reported in patients with spina bifida (myelomeningocele),
particularly when associated with other malformations.
Newer technologies such as array comparative genomic
hybridization (CGH) have made it possible to identify
smaller (submicroscopic) DNA deletions/duplications, also
referred to as copy number variants (CNVs). Submicro-
scopic CNVs have been identified as the cause of a variety
of disorders, substantially increasing the diagnostic yield in
patients with intellectual disability and multiple congenital
malformations. Submicroscopic CNVs have not been
commonly reported in patients with spina bifida, but given
the high frequency of visible chromosome rearrangements,
we hypothesize that submicroscopic CNVs also contribute
to the genetic etiology of spina bifida.
Materials and methods
We reviewed all array CGH results at a single children’s
hospital laboratory for which neural tube defect was
included in the indication for the test. During 2007-
2009, array CGH was performed by the laboratory on a
total of 1988 patients.
Results
Fourteen patients with spina bifida were evaluated by
array CGH during the study period. CNVs were identi-
fied in two patients: 1) A 14 year old male with thoraco-
sacral myelomeningocele, diastematomyelia, shunted
hydrocephalus, bilateral clubfeet, bilateral subependymal
heterotopias, bilateral closed-lip schizencephaly, seizures
and polyarticular juvenile rheumatoid arthritis, had nor-
mal high-resolution karyotype (550-650 band), but array
CGH revealed a 1.3Mb interstitial deletion in16p13.11.
Of note, the patient’s brother has Gorlin syndrome, but
no neural tube defect, and carries the same deletion. Par-
ents have not been tested. 16p13.11 deletion has been
reported in patients with autism, intellectual disability,
epilepsy, holoprosencephaly and other malformations,
but also in a few phenotypically normal individuals.
2) A 14 year old female with thoracic myelomeningocele,
shunted hydrocephalus, bilateral hearing loss and caudal
regression with imperforate anus had a normal high-
resolution karyotype (600-650 band), but array CGH
revealed a 0.4-2.1 Mb duplication in 15q13.3. Mother
does not carry the duplication, father has not been tested
and a 17 year old sister with learning disabilities and
ADHD has not been tested. 15q13.3 duplication has been
reported in patients with intellectual disability, autistic
behaviors and dysmorphic features.
Conclusions
Newer technologies for detecting smaller chromosome
abnormalities may identify the cause of spina bifida in a
proportion of patients. We hypothesize that atypical pre-
sentation may be associated with increased risk of an
underlying CNV. Larger studies are required to deter-
mine the prevalence of CNVs in patients with spina
bifida and whether patients with CNVs display atypical
clinical features.
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